Abstract
Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
| Original language | English |
|---|---|
| Pages (from-to) | 120-120 |
| Number of pages | 1 |
| Journal | Current Cardiology Reports |
| Volume | 17 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Keywords
- Cardiovascular disease
- Gut microbiota
- Obesity
- Platelets
- Type 2 diabetes
Fingerprint
Dive into the research topics of 'Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver